DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1CYMBALTA
02 2DIVALPROEX SODIUM
03 14DULOXETINE HYDROCHLORIDE
04 12ESOMEPRAZOLE MAGNESIUM
05 14LANSOPRAZOLE
06 6OMEPRAZOLE
07 1PREVACID
08 1PREVACID 24 HR
09 1PROZAC WEEKLY
01 120406
02 121235
03 121427
04 122327
05 175347
06 175757
07 175876
08 177255
09 178003
10 178279
11 178936
12 178979
13 190331
14 190723
15 190728
16 190739
17 190745
18 190763
19 190774
20 190776
21 190778
22 190783
23 191269
24 191352
25 191509
26 1201921
27 1202176
28 1202194
29 1202336
30 1202366
31 1202637
32 1202727
33 1202949
34 1203088
35 1203187
36 1203197
37 1203306
38 1203481
39 1203636
40 1204661
41 1205606
42 1205868
43 1206296
44 1207219
45 1207265
46 1208706
47 1209495
48 1210559
49 1212949
50 1213158
51 1213181
52 1213859
01 52No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 78279
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 203481
Country : US
Patented : No
Drug : DULOXETINE HYDROCHLORIDE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 203088
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 75876
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 213158
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 212949
Country : US
Patented : No
Drug : LANSOPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 202727
Country : US
Patented : No
Drug : OMEPRAZOLE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 91352
Country : US
Patented : No
Drug : DULOXETINE HYDROCHLORIDE
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 90728
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED REL PELLETS; ORAL
Application Number : 209495
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?